Full Text of SB1186 101st General Assembly
SB1186 101ST GENERAL ASSEMBLY |
| | 101ST GENERAL ASSEMBLY
State of Illinois
2019 and 2020 SB1186 Introduced 2/5/2019, by Sen. David Koehler SYNOPSIS AS INTRODUCED: |
| |
Creates the Administration of Antibiotics to Food-Producing Animals Act. Provides that a medically important antibiotic may be administered to a food-producing animal only if prescribed by a veterinarian licensed under the Veterinary Medicine and Surgery Practice Act of 2004 who has visited the farm operation within the previous 6 months and only if deemed necessary for specified purposes. Provides that a producer may provide a medically important antibiotic to a food-producing animal only for the period necessary to accomplish the specified purposes. Provides that in that case, antibiotics should be used on the smallest number of animals and for the shortest time possible. Provides that a producer shall keep a record of the specific beginning and ending dates for the provision of an antibiotic. Provides that provisions concerning the administration of antibiotics to food-producing animals take effect on January 1, 2021. Requires a producer that operates a large concentrated animal feeding operation, as defined by the United States Environmental Protection Agency, to file an annual report containing specified information in a form and manner required by the Department of Public Health by rule. Provides that, except for the identities of individual producers, all information reported to the Department under the Act shall be public record, to be made available on the Department's website. Provides that the Department may take the actions necessary to prepare to implement the provisions of the Act in advance of the effective date of the other provisions of the Act. Provides that the Attorney General has the exclusive authority to enforce the Act, may issue a civil penalty up to $1,000 for a violation of the Act, and may seek an injunction to prevent a violation of the Act.
|
| |
| | | FISCAL NOTE ACT MAY APPLY | |
| | A BILL FOR |
|
| | | SB1186 | | LRB101 07905 CPF 52960 b |
|
| 1 | | AN ACT concerning health.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 1. Short title. This Act may be cited as the | 5 | | Administration of Antibiotics to Food-Producing Animals Act. | 6 | | Section 5. Findings; purpose. | 7 | | (a) The General Assembly finds and declares that: | 8 | | (1) the World Health Organization has stated that | 9 | | "without urgent, coordinated action by many stakeholders, | 10 | | the world is headed for a post-antibiotic era, in which | 11 | | common infections and minor injuries which have been | 12 | | treatable for decades can once again kill"; | 13 | | (2) the United States Food and Drug Administration and | 14 | | the Centers for Disease Control and Prevention have stated | 15 | | that there is a definitive link between the use of | 16 | | antibiotics on industrial farms and the crisis of | 17 | | antibiotic resistance in humans; | 18 | | (3) the issue of antibiotics overuse, whether on humans | 19 | | or animals, is a significant and urgent human health | 20 | | matter; | 21 | | (4) the World Health Organization recommends "complete | 22 | | restriction of use of all classes of medically important | 23 | | antimicrobials in food-producing animals for prevention of |
| | | SB1186 | - 2 - | LRB101 07905 CPF 52960 b |
|
| 1 | | infectious diseases that have not yet been clinically | 2 | | diagnosed"; | 3 | | (5) nearly 70% of medically important antibiotics sold | 4 | | in the United States are given to food-producing animals, | 5 | | often to compensate for the effects of unsanitary and | 6 | | overcrowded living conditions;
| 7 | | (6) many of the antibiotics provided to food-producing | 8 | | animals are identical to, or from the same family as, drugs | 9 | | used in human medicine to cure serious diseases; therefore, | 10 | | bacterial resistance to these drugs poses a threat to human | 11 | | health because these drugs may not work to treat human | 12 | | disease when needed; and | 13 | | (7) passing this Act is necessary to protect the health | 14 | | and safety of Illinois consumers from antibiotic resistant | 15 | | bacteria spreading through the food supply.
| 16 | | (b) The purpose of this Act is to protect public health by | 17 | | preserving the effectiveness of antibiotics now and for future | 18 | | generations by eliminating the use of those important medicines | 19 | | in food-producing animals for disease prevention, in order to | 20 | | reduce the rise and spread of antibiotic resistant bacteria.
| 21 | | Section 10. Definitions. As used in this Act: | 22 | | "Control the spread of a disease or infection" means the | 23 | | use of a medically important antibiotic to stop the | 24 | | transmission of a documented disease or infection present in: | 25 | | (1) a group of animals in contact with each other; or |
| | | SB1186 | - 3 - | LRB101 07905 CPF 52960 b |
|
| 1 | | (2) a barn or equivalent animal housing unit.
| 2 | | "Department" means the Department of Public Health. | 3 | | "Disease prevention" means the administration of a | 4 | | medically important antibiotic to an animal or multiple animals | 5 | | in the absence of contact with animals with a clinically | 6 | | diagnosed disease for the purpose of avoiding illness. | 7 | | "Food-producing animal" means: | 8 | | (1) cattle, swine, or poultry, regardless of whether | 9 | | the specific animal is raised for the purpose of producing | 10 | | food for human consumption; or | 11 | | (2) any type of animal that the Department identifies | 12 | | by rule as livestock typically used to produce food for | 13 | | human consumption.
| 14 | | "Medically important antibiotic" means a drug that is | 15 | | composed in whole or in part of a drug from an antimicrobial | 16 | | class that is categorized as critically important, highly | 17 | | important, or important in the World Health Organization list | 18 | | of Critically Important Antimicrobials for Human Medicine (5th | 19 | | Revision, 2017), or a subsequent revision or successor document | 20 | | issued by the World Health Organization. | 21 | | "Producer" means a person or entity that establishes | 22 | | management and production standards for the maintenance, care, | 23 | | and raising of food-producing animals and that: | 24 | | (1) operates a business raising food-producing animals | 25 | | that are used to produce any product group sold by a | 26 | | grocer; or |
| | | SB1186 | - 4 - | LRB101 07905 CPF 52960 b |
|
| 1 | | (2) purchases or otherwise obtains live food-producing | 2 | | animals that it slaughters, or sells for slaughter, for | 3 | | production of any product group sold by a grocer.
| 4 | | "Treat a disease" means administering a medically | 5 | | important antibiotic to infected individual animals or | 6 | | populations of animals to resolve clinical signs of infection | 7 | | or illness.
| 8 | | Section 15. Administration of antibiotics to | 9 | | food-producing animals. | 10 | | (a) This Section applies to the provision of medically | 11 | | important antibiotics to food-producing animals on or after | 12 | | January 1, 2021. | 13 | | (b) A medically important antibiotic may be administered to | 14 | | a food-producing animal only if prescribed by a veterinarian | 15 | | licensed under the Veterinary Medicine and Surgery Practice Act | 16 | | of 2004 who has visited the farm operation within the previous | 17 | | 6 months and only if deemed necessary: | 18 | | (1) to treat a disease; | 19 | | (2) to control the spread of a disease or infection; or | 20 | | (3) in relation to a surgical or other medical | 21 | | procedure that exposes normally sterile body sites to | 22 | | infection. | 23 | | (c) A producer may provide a medically important antibiotic | 24 | | to a food-producing animal only for the period necessary to | 25 | | accomplish a purpose described in subsection (b). In that case, |
| | | SB1186 | - 5 - | LRB101 07905 CPF 52960 b |
|
| 1 | | antibiotics should be used on the smallest number of animals | 2 | | and for the shortest time possible. In addition to any | 3 | | information described in Section 20, the producer shall keep a | 4 | | record of the specific beginning and ending dates for the | 5 | | provision of an antibiotic. | 6 | | (d) A medically important antibiotic may not be | 7 | | administered to food-producing animals solely for the purpose | 8 | | of:
| 9 | | (1) promoting weight gain; | 10 | | (2) improving feed efficiency; or | 11 | | (3) disease prevention. | 12 | | Section 20. Annual report. | 13 | | (a) A producer that operates a large concentrated animal | 14 | | feeding operation, as defined by the United States | 15 | | Environmental Protection Agency, must file an annual report | 16 | | under this Section in a form and manner required by the | 17 | | Department by rule. If the producer and a contracting entity | 18 | | enter into an agreement for the contracting entity to assume | 19 | | the annual report filing duty, the contracting entity shall | 20 | | include in the annual report the name and address of the | 21 | | producer on whose behalf the contracting entity is submitting | 22 | | the annual report. If any medically important antibiotics were | 23 | | provided to food-producing animals during the reporting | 24 | | period, then the annual report must contain the following | 25 | | information: |
| | | SB1186 | - 6 - | LRB101 07905 CPF 52960 b |
|
| 1 | | (1) the location of the facility where the medically | 2 | | important antibiotic was used; | 3 | | (2) the medically important antibiotic and class of | 4 | | antimicrobial used; | 5 | | (3) the duration of use, including the number of | 6 | | treatment days; | 7 | | (4) the species and production class of animals | 8 | | receiving the medically important antibiotic; | 9 | | (5) the number of animals receiving the medically | 10 | | important antibiotic; | 11 | | (6) the total number of animals raised at the facility, | 12 | | this data is key to understanding variations in use and | 13 | | benchmarking performance; | 14 | | (7) the indication and purpose for which the | 15 | | veterinarian prescribed the medically important | 16 | | antibiotic; | 17 | | (8) the dosage of the medically important antibiotic; | 18 | | (9) the quantity of each medically important | 19 | | antibiotic prescribed to each species of food-producing | 20 | | animal; | 21 | | (10) the method for providing each medically important | 22 | | antibiotic to a food-producing animal; and
| 23 | | (11) any other information required to be kept pursuant | 24 | | to U.S. Food and Drug Administration regulations 21 CFR | 25 | | 558.6(b)(3) and 21 CFR 558.6(b)(4).
| 26 | | (b) Information provided under paragraph (7) of subsection |
| | | SB1186 | - 7 - | LRB101 07905 CPF 52960 b |
|
| 1 | | (a) must include whether a medically-important antibiotic was | 2 | | provided to a food-producing animal for the purpose of: | 3 | | (1) surgery or a medical procedure; | 4 | | (2) disease control; or | 5 | | (3) disease treatment. | 6 | | (c) Information reported under this Section shall be made | 7 | | publicly available by the Department annually in a searchable | 8 | | database of aggregated data on its website, except that the | 9 | | Department shall withhold the identities of individual | 10 | | producers. | 11 | | (d) Except as otherwise provided in subsection (c), | 12 | | information reported under this Section is a public record and | 13 | | is not subject to exemption from disclosure. The Department may | 14 | | not redact, withhold, or delay the release of information, | 15 | | except the identities of individual producers pursuant to | 16 | | subsection (c), reported under this Section. | 17 | | (e) The Department of Public Health shall consult with the | 18 | | Department of Agriculture as necessary to fulfill the | 19 | | requirements of this Section. | 20 | | Section 25. Implementation. The Department may take the | 21 | | actions necessary to prepare to implement the provisions of | 22 | | this Act in advance of the effective date of the other | 23 | | provisions of this Act. | 24 | | Section 30. Violations. The Attorney General has exclusive |
| | | SB1186 | - 8 - | LRB101 07905 CPF 52960 b |
|
| 1 | | authority to enforce the provisions of this Act. Each violation | 2 | | of this Act is punishable by a civil penalty not to exceed | 3 | | $1,000. The Attorney General may also seek injunctive relief to | 4 | | prevent further violations of this Act.
|
|